# China NMPA Drug Inspection - Guangdong Bidi Pharmaceutical Co., Ltd. - Acyclovir tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bidi-pharmaceutical-co-ltd/496f906b-7011-4317-8ee0-76cb2856ccf6/
Source feed: China

> China NMPA drug inspection for Guangdong Bidi Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Acyclovir tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangdong Bidi Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Acyclovir tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangdong-bidi-pharmaceutical-co-ltd/9e579f82-a219-49c9-ba98-ac135c1c6832/